By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

DelSite Biotechnologies, Inc. 

1505 Walnut Hill Lane

Irving  Texas  75038  U.S.A.
Phone: 972-717-5009 Or 800-358-5213
Fax: 972-871-1132


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
DelSite Biotechnologies, Inc. Announces Intention to License Manapol(R) Manufacturing Rights, Fields of Use and Territories 2/18/2009 11:23:17 AM
DelSite Biotechnologies, Inc.. Discontinues Manufacturing Operations; Receives FDA Approval to Initiate Phase I Clinical Study for GelVac(TM) Nasal Powder Bird Flu Vaccine 1/26/2009 12:04:45 PM
DelSite Biotechnologies, Inc. Chairman George DeMott Resigns 12/11/2008 11:40:55 AM
DelSite Biotechnologies, Inc. Presents Nasal Powder and Synthetic Typhoid Vaccine Technologies at the 2nd Vaccines Asia Conference 11/13/2008 11:06:48 AM
DelSite Biotechnologies, Inc. Reports Third Quarter 2008 Results 11/13/2008 9:44:13 AM
DelSite Biotechnologies, Inc. Patent for GelSite(R) Polymer Technology Issued 11/12/2008 9:11:31 AM
DelSite Biotechnologies, Inc. Announces Third Quarter 2008 Earnings Conference Call 11/11/2008 11:29:38 AM
DelSite Biotechnologies, Inc. Files IND for Nasal Powder H5N1 (Bird Flu) Influenza Vaccine 8/20/2008 11:26:30 AM
DelSite Biotechnologies, Inc. Nasal Powder Vaccine Platform Highlighted At Cambridge Healthtech Institute 8/18/2008 11:20:51 AM
DelSite Biotechnologies, Inc. Reports Second Quarter 2008 Results 8/14/2008 9:25:24 AM
1234567
//-->